作者: Michael D. Combs , Paul J. Perry , Kristine A. Bever
DOI: 10.1002/J.1875-9114.1997.TB03096.X
关键词:
摘要: We reviewed the charts of 58 patients with treatment-refractory schizophrenia who were receiving clozapine, to determine if drug's active metabolite, N-desmethylclozapine, is a biologic marker for impending clozapine-induced granulocytopenia and agranulocytosis. No significant correlation between granulocyte counts patient demographic variables clozapine N-desmethylclozapine steady-state plasma concentrations, clozapine:N-desmethylclozapine ratio, age, gender, dosage, smoking status, race found. believe not clinically useful monitoring effect on integrity. On contrary, its concentrations correlated positively counts.